Oral PCA
Dietary SupplementPCA 1,000 mg BID until surgery, held until anticoagulation, and resumed at 1,000 mg daily for 4 years
NCT Number: NCT06591741
Determine if dietary protocatechuic acid (PCA) will affect health biomarkers in patient undergoing revision surgery for a knee prosthetic joint infection
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
Patients who are scheduled to undergo revision surgery for a knee prosthetic joint infection are given PCA prior to surgery for a time period determined by a previous pilot study. PCA is then post-operatively until anticoagulation is stopped, and then will be resumed for four years post revision surgery. Measurement of changes in glucose control, immunity, will be measured over the first 3 months post-revision, and the post-revision reinfection rate over the full 4 years will be compared to a cohort rate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PCA 1,000 mg BID until surgery, held until anticoagulation, and resumed at 1,000 mg daily for 4 years
Time frame: 0 and 3 months
Time frame: 0 and 3 months
Time frame: 0 to 4 years
Contact information is provided by the study sponsor or research team.
Kenneth D Reeves, M.D.
CONTACT
Lanny Johnson, M.D.
CONTACT
Dr. Dean Reeves Clinic
Other
Effects of Dietary Protocatechuic Acid (PCA) on the Function and Structure of Participants With Knee Prosthetic Joint Infection (PJI) as Measured by Standard Biomarkers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07322289
Debridement With Prosthesis Retention, Prosthetic Joint Infection
Miami, Florida, United States
View Trial DetailsNCT07426471
Arthritis, Arthritis, Infectious
View Trial DetailsNCT07409402
Prosthetic Joint Infection
Paris, France
View Trial DetailsNCT05169229
Antibiotic Resistant Infection, Arthritis
Linköping, Region Östergotland, Sweden
View Trial Details